Quantitative Top–Down Proteomics Reveals Significant Differences in Histone Proteoforms Between Metastatic and Nonmetastatic Colorectal Cancer Cells
PROTEOMICS · 2025-12 · 25 (24) · 88-98
DOI: 10.1002/pmic.202400336 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 17.04.2025. Verfasst von Fei Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Histones, Colorectal Neoplasms, Proteomics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Colorectal cancer (CRC) development is closely associated with the accumulation of both genetic and epigenetic alterations. Many efforts have been made to investigate the role of epigenetic modifications in CRC metastasis. In this work, we present the quantitative top‐down proteomics study focusing on histone proteoforms between metastatic (SW620) and nonmetastatic (SW480) CRC cells to reveal potentially critical histone proteoforms in CRC metastasis. We isolated histone proteins from CRC cells, fractionated them by sodium dodecyl‐sulfate (SDS)‐polyacrylamide gel electrophoresis (PAGE), and analyzed them by capillary zone electrophoresis (CZE)‐tandem mass spectrometry (MS/MS). A total of 230 histone proteoforms were quantified in SW480 and SW620 cell lines, among which 34 proteoforms were significantly altered in abundance in the metastatic cells, indicating a significant transformation of histone proteoforms during metastasis. We observed a significant increase in abundance of all nine differentially expressed histone H4 proteoforms in metastatic SW620 cells compared to SW480 cells, while differentially expressed proteoforms of other histone proteins display diversified expression patterns. Additionally, two histone H2A proteoforms with a combination of N‐terminal acetylation and phosphorylation were upregulated in the metastatic CRC cells. These differentially expressed histone proteoforms could be novel proteoform biomarkers of CRC metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Michigan State University, East Lansing, Michigan, USA.
- Department of Chemistry and Biochemistry, Ohio State University, Columbus, Ohio, USA.
- Department of Computer Science, School of Science & Engineering, Tulane University, New Orleans, Louisiana, USA.
- Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
ORCID-Profile: Zhige Wang, Xiaowen Liu, Amanda B Hummon, Liangliang Sun
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Fang, F., Fries, B., Wang, Z., Liu, X., Hummon, A. B., & Sun, L. (2025). Quantitative Top–Down Proteomics Reveals Significant Differences in Histone Proteoforms Between Metastatic and Nonmetastatic Colorectal Cancer Cells. PROTEOMICS, 25(24), 88-98. https://doi.org/10.1002/pmic.202400336
Vancouver
Fang F, Fries B, Wang Z, Liu X, Hummon AB, Sun L. Quantitative Top–Down Proteomics Reveals Significant Differences in Histone Proteoforms Between Metastatic and Nonmetastatic Colorectal Cancer Cells. PROTEOMICS. 2025;25(24):88-98. doi:10.1002/pmic.202400336
BibTeX
@article{Fang2025,
author = {Fang, Fei and Fries, Brian and Wang, Zhige and Liu, Xiaowen and Hummon, Amanda B and Sun, Liangliang},
title = {Quantitative Top–Down Proteomics Reveals Significant Differences in Histone Proteoforms Between Metastatic and Nonmetastatic Colorectal Cancer Cells},
journal = {PROTEOMICS},
year = {2025},
volume = {25},
number = {24},
pages = {88--98},
doi = {10.1002/pmic.202400336}
}
EUVIMED